Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables
- 3 August 2020
- journal article
- research article
- Published by Wiley in Journal of Biophotonics
- Vol. 13 (10) , e201960235
Abstract
Use of genomic assays to determine distant recurrence risk in patients with early stage breast cancer has expanded and is now included in the American Joint Committee on Cancer staging manual. Algorithmic alternatives using standard clinical and pathology information may provide equivalent benefit in settings where genomic tests, such as OncotypeDx, are unavailable. We developed an artificial neural network (ANN) model to nonlinearly estimate risk of distant cancer recurrence. In addition to clinical and pathological variables, we enhanced our model using intraoperatively determined global mammographic breast density (MBD) and local breast density (LBD). LBD was measured with optical spectral imaging capable of sensing regional concentrations of tissue constituents. A cohort of 56 ER+ patients with an OncotypeDx score was evaluated. We demonstrated that combining MBD/LBD measurements with clinical and pathological variables improves distant recurrence risk prediction accuracy, with high correlation (r = 0.98) to the OncotypeDx recurrence score.Keywords
Funding Information
- National Institutes of Health (R01EB011574‐01A1)
- National Science Foundation (Graduate Research Fellowship)
- Small Business Innovative Research and Small Business Technology Transfer (2R42CA128160‐02)
- U.S. Department of War (W81XWH‐09‐1‐0410)
This publication has 69 references indexed in Scilit:
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysisLaboratory Investigation, 2013
- Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancerBreast Cancer Research, 2012
- Microtubules regulate GEF-H1 in response to extracellular matrix stiffnessMolecular Biology of the Cell, 2012
- High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance StudyJournal of Clinical Oncology, 2011
- Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast CancerJournal of Clinical Oncology, 2011
- Rapid noninvasive optical imaging of tissue composition in breast tumor marginsThe American Journal of Surgery, 2009
- A Robust Monte Carlo Model for the Extraction of Biological Absorption and Scattering In VivoIEEE Transactions on Biomedical Engineering, 2008
- Collagen density promotes mammary tumor initiation and progressionBMC Medicine, 2008
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004